ENL 47.16 Reed Elsevier Nv $ENL Hit a 52 week high of 47.17

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
ENL 47.16 Reed Elsevier Nv $ENL Hit a 52 week high of 47.17 Closing the day 09:44 at 47.16 -0.17 -0.36% With a day low of 47.12 and a total volume of 1,950.

ENL Recent Posts: http://investorshangout.com/Reed-Elsevier-NV-ENL-50879/

ENL Reed Elsevier Nv Recent Headline News

Elsevier Publishes New Books on Chemical and Process Engineering
Marketwire Canada - Wed Nov 19, 3:00AM CST
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of six new books on chemical and process engineering, expanding the portfolio for researchers, practitioners and students. Included in the list of books is the fifth edition of the three-volume, in-depth reference work Physical Metallurgy, edited by distinguished academics and metallurgists Professor David Laughlin of Carnegie Mellon University and Kazuhiro Hono of University of Tsukuba, Japan.
RUK: 66.52 (-0.31), ENL: 47.03 (-0.30)

Elsevier Expands Neuroscience Portfolio With Eight New Books
Marketwire Canada - Mon Nov 17, 7:45AM CST
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the expansion of its neuroscience portfolio with eight new neuroscience books. These include the long-awaited fourth edition of The Rat Nervous System, edited by award-winning researcher, professor and author Dr. George Paxinos. The book's completely revised and updated content extends its reputation as the gold-standard reference for rat neuroanatomy. These and other books in its neuroscience portfolio are on display at Elsevier booth #115 at the Society for Neuroscience (SfN) annual meeting in Washington, DC, November 16-19.
RUK: 66.52 (-0.31), ENL: 47.03 (-0.30)

Elsevier Publishes Four New Books in Environmental Sciences Portfolio
Marketwired - Wed Nov 12, 3:00AM CST
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of four new environmental science books offering the latest information on the study of soil and water, including the fourth edition of Soil Microbiology, Ecology and Biochemistry, written by Eldor Paul, Senior Research Scientist at the Natural Resources Ecology Laboratory at Colorado State University, Fort Collins, and Professor Emeritus at Michigan State University.
RUK: 66.52 (-0.31), ENL: 47.03 (-0.30)

Sentrian, the World's First Remote Patient Intelligence Company, Launches to Eliminate Preventable Hospitalization
PR Newswire - Mon Nov 10, 7:03AM CST
Sentrian(TM) (formally Jointly Health), the Remote Patient Intelligence(TM) company aspiring to eliminate all preventable hospitalization, formally launched today at Singularity University's Exponential Medicine Conference.
RUK: 66.52 (-0.31), IBM: 161.52 (-0.37), ENL: 47.03 (-0.30)

LexisNexis: Homegrown Cardiff Company, Tracesmart(R), Creates 40 New Jobs in Cardiff
Business Wire - Wed Oct 15, 8:02AM CDT
Tracesmart, a company founded and headquartered in Cardiff, Wales, will be creating 40 jobs by the end of the year, increasing employee numbers by more than 50 percent. The new roles, based in Cardiff, include highly skilled IT developers and engineers and will support Tracesmart as it becomes the U.K. center of excellence for LexisNexis(R) Risk Solutions which acquired the company in April 2014. For more than 12 years, LexisNexis Risk Solutions has been one of the fastest-growing divisions and a key area of strategic focus of its parent company, Reed Elsevier(R), one of the world's leading providers of digital content and professional information solutions.
RUK: 66.52 (-0.31), ENL: 47.03 (-0.30)

Will John Wiley Gain from Transition to Digital Media? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 26, 11:20AM CDT
John Wiley & Sons (JW.A) is transitioning to digitization due to soft demand for print media and recent acquisitions have a vital role to play in this. Inorganic expansion is being pursued aggressively at John Wiley and is yielding positive results as evident from the company???s first quarter fiscal 2015 results.
SCHL: 34.32 (-0.22), ENL: 47.03 (-0.30), SSP: 19.56 (-0.08), JW.A: 58.40 (-0.39)

Elsevier Publishes New Content on Graphene and Materials Science
Marketwire Canada - Thu Sep 25, 3:00AM CDT
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of new content on graphene and materials science, including Graphene: Properties, Preparation, Characterisation and Devices by Viera Skakalova and Alan Kaiser. Carbon nanotubes, graphene and nanomaterials are emerging and increasingly important materials with many applications in medicine, computing, optics, energy and materials science.
RUK: 66.52 (-0.31), ENL: 47.03 (-0.30)

Elsevier Publishes New Books on Bone and Endocrine Disease
Marketwire Canada - Thu Sep 11, 3:54AM CDT
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of four new books on bone and endocrine disease, including Bone Cancer, 2nd Edition: Primary Bone Cancers and Bone Metastases by Dominique Heymann. These biomedical science books will be on display in Elsevier's booth #101 at the upcoming American Society for Bone and Mineral Research (ASBMR) 2014 Annual Meeting, September 12-15 in Houston, TX.
RUK: 66.52 (-0.31), ENL: 47.03 (-0.30)

John Wiley Beats Q1 Earnings on Strategic Acquisitions - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 10, 9:00AM CDT
John Wiley & Sons Inc. (JW-A) reported first-quarter fiscal 2015 adjusted earnings per share of 56 cents that topped the Zacks Consensus Estimate while rising 10% year over year driven by acquisitions.
SCHL: 34.32 (-0.22), ENL: 47.03 (-0.30), JW.A: 58.40 (-0.39)

Elsevier Publishes New Chemical Engineering Content
Marketwire Canada - Wed Sep 03, 3:00AM CDT
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that new chemical engineering content is available. This content includes three new books on industrial distillation and two additional books on flow analysis and water reclamation. These books provide researchers and graduate students with latest knowledge required for those working in the oil, petrochemical, chemical, pharmaceutical and environmental industries.
RUK: 66.52 (-0.31), ENL: 47.03 (-0.30)

Elsevier to Market Innovative Patient Data Collection Platform from Tonic Health
PR Newswire Europe - Tue Sep 02, 11:24AM CDT
PHILADELPHIA, Pennsylvania, September 2, 2014 /PRNewswire/ --
RUK: 66.52 (-0.31), ENL: 47.03 (-0.30)

Elsevier Announces the Launch of Open Access Journal: 'Neurobiology of Stress'
PR Newswire Europe - Thu Aug 14, 7:19AM CDT
OXFORD, England, August 14, 2014 /PRNewswire/ --
RUK: 66.52 (-0.31), ENL: 47.03 (-0.30)

Elsevier Announces 2013 Journal Impact Factor Highlights
PR Newswire Europe - Thu Aug 14, 7:03AM CDT
AMSTERDAM, August 14, 2014 /PRNewswire/ --
RUK: 66.52 (-0.31), ENL: 47.03 (-0.30)

Elsevier Publishes First Edition of Non-Operating Room Anesthesia
PR Newswire Europe - Fri Aug 01, 6:42AM CDT
PHILADELPHIA, August 1, 2014 /PRNewswire/ --
RUK: 66.52 (-0.31), ENL: 47.03 (-0.30)

Elsevier Announces the Launch of Open Access Journal: Oral and Maxillofacial Surgery Cases
PR Newswire Europe - Mon Jul 28, 8:28AM CDT
NEW YORK, July 28, 2014 /PRNewswire/ --
RUK: 66.52 (-0.31), ENL: 47.03 (-0.30)

RELX N.V. (RENX) Stock Research Links

RENX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 312

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 350

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 303

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 330

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 638

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 342

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 479

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 389

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 122

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 182

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading

Top 5 Most Recently Viewed Articles

HALiXPEDITE Revolutionizes Biologics Therapy Development Process

Updated Category News Views 147

HALiXPEDITE: Transforming the Future of Biologics Development HALIX, a prominent global healthcare Contract Development and Manufacturing Organization (CDMO), recently unveiled its innovative platform, HALiXPEDITE, at a notable conference. This platform is specifically designed to expedite the development of biologics therapies, focusing on a streamlined approach to...

Continue Reading
Day One Biopharmaceuticals to Share Q3 2025 Insights

Updated Category News Views 170

Day One Biopharmaceuticals to Present Q3 2025 Financial Results In a busy season for the biopharmaceutical industry, Day One Biopharmaceuticals (Nasdaq: DAWN) has announced it will host a live conference call and webcast aimed at reporting its financial results and outlining corporate progress for the third quarter of 2025. Conference Call Details The event is scheduled...

Continue Reading
Leica Biosystems Promotes DICOM Standards for Digital Pathology

Updated Category News Views 114

Leica Biosystems Promotes DICOM Standards for Digital Pathology Leica Biosystems, a prominent figure in anatomic pathology, has recently made waves in the medical field with a bold new initiative. By announcing the non-enforcement of their Digital Pathology DICOM (Digital Imaging and Communications in Medicine) patent portfolio, they aim to boost the implementation of...

Continue Reading
LYNPARZA: A Breakthrough in Early Breast Cancer Treatments

Updated Category News Views 288

Significant Survival Benefits with LYNPARZA in Breast Cancer Recent findings from the OlympiA Phase III trial bring exciting news for patients battling early breast cancer. AstraZeneca and Merck & Co., Inc.'s LYNPARZA (olaparib) has showcased profound improvements in survival rates among patients with germline BRCA-mutated HER2-negative high-risk early breast cancer. This...

Continue Reading
EuroDry Limited's Stock Experiences Volatility Amid Challenges

Updated Category News Views 229

EuroDry Limited Faces Stock Turmoil EuroDry Ltd. (NASDAQ: EDRY), a leading provider in drybulk shipping, has recently encountered a tumultuous phase, with its stock reaching a noteworthy low at $14.1. This decline marks a significant reflection on the year's challenges the company has faced, indicated by a -14.71% change over the past year. Market Conditions and...

Continue Reading